Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects

Summary

This Phase I clinical study is to evaluate the safety and tolerance of DA-3091 and to characterize the pharmacokinetic/pharmacodynamic of DA-3091 in healthy male subjects

Timeline

Start

2010-07

Primary completion

2012-04

Completion

—

Drugs

Indications